Indus Nephrology Private Limited

Founded in 2016 and headquartered in Delhi, India.

2016 | Central Delhi, Delhi (India) | Inactive
Last Updated: April 02, 2024

Indus Nephrology Profile

Key Indicators

  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 1.61 M
  • Company Age 8 Year, 4 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth %
  • Profit Growth 91.89%
  • Ebitda 92.61%
  • Net Worth -73.01%
  • Total Assets -49.13%

About Indus Nephrology

Indus Nephrology Private Limited (INPL) is Strike Off company established on 07 Sep 2016 with its office registered at Central Delhi, Delhi, India and has been running since 8 Year, 4 Months with a paid up capital of 1.61 M. According to MCA records, 2 Directors are linked to this company as of 02 Apr 2024.

Company Details

  • Location

    Central Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74999DL2016PTC305572

  • Company No.

    305572

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    07 Sep 2016

  • Date of AGM

    30 Nov 2021

  • Date of Balance Sheet

    31 Mar 2021

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Business Services

Who are the key members and board of directors at Indus Nephrology?

Board Members (2)

Name Designation Appointment Date Status
Upendra Raina Country flag representing In Director 29-Dec-2016 Current
Kulwant Anand Country flag representing In Director 07-Sep-2016 Current

Financial Performance of Indus Nephrology.

Indus Nephrology Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 91.89% increase in profit. The company's net worth observed a substantial decline by a decrease of 73.01%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-49.13%
Profit or Loss
91.89%
Net Worth
-73.01%
EBITDA
92.61%

What is the Ownership and Shareholding Structure of Indus Nephrology?

In 2017, Indus Nephrology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Indus Nephrology?

Unlock and access historical data on people associated with Indus Nephrology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Indus Nephrology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Nephrology's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Indus Nephrology

Recent activity within the organization

  • Annual General Meeting

    Indus Nephrology Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.

    30 Nov 2021

  • Balance Sheet

    Indus Nephrology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi.

    31 Mar 2021

  • Director Appointment

    Upendra Raina was appointed as a Director was appointed as a Director on 29 Dec 2016 & has been associated with this company since 8 years 1 month .

    29 Dec 2016

  • Director Appointment

    Kulwant Bir Singh Anand was appointed as a Director was appointed as a Director on 07 Sep 2016 & has been associated with this company since 8 years 4 months .

    07 Sep 2016

  • Company Incorporation

    Indus Nephrology Private Limited was registered on 07 Sep 2016 with Roc Delhi & aged 8 years 4 months as per MCA records.

    07 Sep 2016

Frequently asked questions

  • Indus Nephrology Private Limited was incorporated on 07 Sep 2016.

  • The authorized share capital of Indus Nephrology Private Limited is ₹ 2.00 M and paid-up capital is ₹ 1.61 M.

  • Currently 2 directors are associated with Indus Nephrology Private Limited.

    • Upendra Raina
    • Kulwant Bir Singh Anand
  • As per Ministry of Corporate Affairs (Mca), the registered address of Indus Nephrology Private Limited is 26/8 Basement, Old Rajinder Nagar, Delhi, India, 110060.

  • The corporate identification number (CIN) of Indus Nephrology Private Limited is U74999DL2016PTC305572 and the company number is 305572 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2020 indicates that The net worth of Indus Nephrology Private Limited has experienced an downturn of -73.01%.

  • The most recent Balance Sheet for Indus Nephrology Private Limited was filed with the ROC on 31 Mar 2021.

People also Viewed

Similar Companies Based on Other Services